ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,991Medicare Part D Prescriptions Filled, Including Refills

Rank: 228 out of 1844

$481K Total Retail Price of All Prescriptions

Rank: 388 out of 1844

416 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 416 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 416 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 7,099 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 428 324 1 4
FUROSEMIDE 396 326 2 7
LEVOTHYROXINE SODIUM 316 234 3 1
POTASSIUM CHLORIDE 280 195 4 16
HYDROCODONE-ACETAMINOPHEN 275 180 S3 5 2
SIMVASTATIN 249 196 6 3
OMEPRAZOLE 240 106 7 5
WARFARIN SODIUM 212 180 8 13
AMLODIPINE BESYLATE 184 156 9 6
NEXIUM 146 95 10 31
RANITIDINE HCL 136 72 11 38
METOPROLOL TARTRATE 136 121 11 11
TRAMADOL HCL 127 87 13 18
POLYETHYLENE GLYCOL 3350 127 75 13 39
METOPROLOL SUCCINATE 121 90 15 14
ALLOPURINOL 121 107 15 29
LOVASTATIN 121 86 15 44
GABAPENTIN 115 74 18 15
PRAVASTATIN SODIUM 114 94 19 10
HYDROCHLOROTHIAZIDE 110 66 20 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 97 21 20
CRESTOR 106 100 22 30
DIGOXIN 105 101 23 67
METFORMIN HCL 96 79 24 8
ATORVASTATIN CALCIUM 93 71 25 12
CARVEDILOL 92 83 26 22
ALENDRONATE SODIUM 90 70 27 25
LABETALOL HCL 89 58 28 223
CLONIDINE HCL 88 82 29 64
ESCITALOPRAM OXALATE 87 77 30 52
CEPHALEXIN 87 61 30 56
ATENOLOL 79 68 32 17
LOSARTAN POTASSIUM 77 76 33 24
CLOPIDOGREL 73 67 34 34
ZOLPIDEM TARTRATE 73 56 34 23
FENOFIBRATE 73 73 34 71
OXYBUTYNIN CHLORIDE 67 23 37 103
PROAIR HFA 67 39 37 45
DIOVAN 67 67 37 58
GLYBURIDE-METFORMIN HCL 65 50 R 40 140
DILTIAZEM 24HR CD 65 64 40 132
PLAVIX 64 60 42 61
CELEBREX 63 27 43 91
MELOXICAM 60 48 44 28
PHENYTOIN SODIUM EXTENDED 58 27 45 147
TAMSULOSIN HCL 56 56 46 27
DILTIAZEM 24HR ER 55 43 47 146
DIVALPROEX SODIUM 53 24 48 74
SERTRALINE HCL 52 28 49 21
CYMBALTA 51 13 50 36
PANTOPRAZOLE SODIUM 50 33 51 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.